Very strong recommendation #PVI

Stronger together, our collaboration with healthcare professionals and patients produces data and insight to improve health outcomes. We will share our #Eluvia clinical trial learnings at VIVA Congress (Oct 6) to better treat peripheral artery diseases #EMINENT

#eminentRCT release is coming soon The VIVA Foundation to know more about #ELUVIA vs #BMS for #femoropolpliteal lesions. Next Wednesday october 6th.

Monitoring 775 patients over a year, we've held the largest randomized trial of a drug-eluting stent for the treatment of PAD to date. Prof. Goueffic will share on Oct. 6 at 18h28 how Eluvia DES compares with Bare Metal Stents at #VIVA21 bit.ly/2YhVsxk

It's today! At 18h28 (CET) Prof. Goueffic will disclose the results of the EMINENT RCT, evaluating the superiority of Eluvia DES vs Bare Metal Stent at #VIVA21 bit.ly/2YhVsxk #EvidenceBasedMedicine #EluviaDES #EMINENT

#EMINENT RCT results presented @ #VIVA21 show #EluviaDES superior to BMS w/ KM primary patency 85.4% vs 76.3%, p=0.0087 at 1yr. also significantly > improvement in clinical outcomes w/out reintervention (KM PP Eluvia DES 83% vs 76.6% BMS; p=0.0450)

ICYMI: "“The Eluvia DES should be considered as the stent of choice for treating [superficial femoral artery] and proximal popliteal artery lesions of intermediate length,” #VIVA21 Gouëffic yann The VIVA Foundation #CardioTwitter healio.com/news/cardiac-v…

Peter Schneider (Peter Schneider) moderates a discussion on CFA disease w/Drs. Daniela Branzan, Daniel Clair, Tony Das, & Gouëffic yann on how they view endovascular options in cases when open surgery is often the first choice for operators. evtoday.com/articles/2021-…

STEP RCT published in Chander Veer comparing Proglide vs FemoSeal. Significant technical success in FemoSeal arm. Thanks CHU de Nantes, CHU Angers @CHRU_Brest @CHUrennes Centre Hospitalier de Cholet   #PAD #SDD #ambulatory #PVI CIRSE Chirurgie Vasculaire ESVS Terumo Interventional Systems pubmed.ncbi.nlm.nih.gov/34386892/

Lorenzo Patrone Konstantinos Stavroulakis Hany Zayed Koen Deloose Gouëffic yann Shockwave Medical Terumo Interventional Systems CLIfighters Vascupedia Nikos Tsilimparis Vascular News u Thanks for sharing your tips and tricks!!!

It was a pleasure meeting again our vascular surgeon friends and colleagues, and I was honored to be part of the scientific committee of the greatest and most valuable vascular congress PVI. Many thanks Gouëffic yann Koen Deloose Stephan Haulon and Eric Ducasse

Congratulations Gouëffic yann for great results of STEP RCT published CVIR Journal #SafeFemoral #PAD #MedEd #Endovascular #echofirst

Lorenzo Patrone Guillermo Escobar🩸 frank arko Athanasios Saratzis Koen Deloose Gouëffic yann In our paper on long term outcomes of CFA stenting, only 2 patients were lost to follow-up at 24 months and the others had their biplane X-ray. One stent fracture was noted at 6 months follow-up. Those results were confirmed by the randomized trial TECCO.

Venez assister à What’s Up en Vasculaire 2021 : L’émission dédiée à vos pratiques en #vasculaire. Samedi 11 décembre, de 9h à 13h. Inscrivez-vous pour assister en #live à l’émission ou accéder au #replay.   bit.ly/3E6fzho   #innovation #rechercheclinique

Successful session @groupehospitalierparissaintjoseph with this FIRST ALI training on #Bone3D model with the #IndigoSystem @penumbraEMEA

What’s up is coming !!

Thankful for the physician and HCP's who helped us achieve these milestones to advance pt care. Integral new devices, finalizing acquisitions + advancing clinical evidence across #Vascular + #IO. Committed to #Innovation & #EvidenceBasedMedicine to further the field.

Cardiolive at Groupe hospitalier paris saint joseph, April 9th, about cardiovascular disease.